Use may result in positive drug tests, sanctions, and disqualification from competition
Subjects were recruited from patients with nondisabling cerebral infarction (VISP)
You can track your prescription and access refill information directly in your patient portal
The 5mg presentation is well suited for receptor pharmacology studies, peptide characterization, assay development, comparative growth hormone fragment investigations, and analytical method validation
AOD-9604 Research Peptide 5mg AOD-9604 is a synthetic fragment of human growth hormone (amino acids 176-191), originally developed at Monash University
Current Active Batch: ERL-2501-B013-T That verification strengthens the research value of AOD-9604 5mg in settings where purity confirmation and identity review are part of standard laboratory intake before biochemical signaling work or receptor analysis begins